Chief Scientific Officer for The Ohio State University Wexner Medical Center
Vice Dean for Research, Ohio State College of Medicine
Director, Dorothy M. Davis Heart and Lung Research Institute
Peter Mohler, PhD, is the vice dean for Research in the Ohio State College of Medicine, chief scientific officer and director of the Dorothy M. Davis Heart and Lung Research Institute. He has been with The Ohio State University since 2011.
Dr. Mohler’s research is focused on uncovering the mechanisms underlying abnormal heart rhythms and heart failure in children and young adults with the goals of designing new therapies for diseases at the level of the individual as well as population. He has more than 210 peer-reviewed publications including manuscripts in Nature, Cell, Journal of Clinical Investigation, Circulation, Nature Medicine, PNAS and Science Signaling.
As chief scientific officer, Dr. Mohler leads all research operations across the medical center, which includes research strategy, operations, space and facilities, research finances, compliance and research initiatives. He also directs the teams that generate and disseminate best practices for interdisciplinary research and innovation across our health science enterprise. He further develops and implements new platforms for research, including basic and translational research, clinical trials and health services and population research.
Dr. Mohler has received multiple awards, including being named a Pew Scholar, a Kavli Scholar of the National Academy of Sciences and an Outstanding Investigator of the American Heart Association. In 2015 he received the inaugural College of Medicine Distinguished Mentor Award. He serves on the Program Project Grant (PO1) Parent committee for the National Heart Lung and Blood Institute. Dr. Mohler was named an inaugural NIH National Heart Lung and Blood Institute Outstanding Investigator, one of only seven awardees in the cardiovascular sciences in the nation to ever receive this award.
Dr. Mohler is the PI of three additional NIH R01 awards, including one for nearly $3M to solve new genetic mechanisms for atrial fibrillation. He directs an NIH T32 training grant for clinical fellows in cardiovascular medicine, serves as co-PI on three additional R01 awards and is the Ohio State PI for a U54 grant from NHLBI focused on translating research to industry.
He received his PhD from the University of North Carolina at Chapel Hill and performed his fellowship at the Howard Hughes Medical Institute at Duke University Medical Center.